Marnix L. Bosch
CIK: 0001253933
Recent activity
The filings on record name Marnix L. Bosch as Chief Technical Officer of Northwest Biotherapeutics Inc. (NWBO]).
The most recent transaction on file, dated Apr 3, 2023, was reported in a Form 4 filed Apr 5, 2023, 2 days after the transaction date.
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NORTHWEST BIOTHERAPEUTICS INC
Discretionary Trading P&L
Holdings
Marnix L. Bosch files insider reports with the SEC as Chief Technical Officer of Northwest Biotherapeutics Inc. (NWBO]). Signal8 holds 1 reported Form 4/5 transaction by Marnix L. Bosch since Sep 2024. The most recent reported transaction is a grant / award (Form 4 code A) in NWBO], dated Apr 3, 2023.
About Marnix L. Bosch
Marnix L. Bosch (SEC CIK 0001253933) files insider reports with the SEC as Chief Technical Officer of NORTHWEST BIOTHERAPEUTICS INC (NWBO]).
Signal8 holds 1 ownership filing by Marnix L. Bosch, a Form 4, filed on Apr 5, 2023. Those filings report 1 transaction, the latest on Apr 3, 2023. Signal8's Form 4 history starts in Sep 2024.
The business address on Marnix L. Bosch's filings is in BETHESDA, MD.
Recent filings by Marnix L. Bosch
- Apr 3, 2023: Grant or award of NWBO] shares (Form 4, code A).